Brian J Meshkin

Address:

11392 Liberty St, Fulton, MD 20759

VIN:

1GNFC16037J254392

Make:

CHEVROLET

Model:

SUBURBAN

Year:

2007

US Patent:

20190080048, Mar 14, 2019

Filed:

Apr 28, 2016

Appl. No.:

15/570312

Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US

International Classification:

G16H 50/20
C12Q 1/6858
C12Q 1/6883
C12Q 1/6827

Abstract:

There are systems and methods for preparing or using prognostic information about opioid response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining an opioid response associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

US Patent:

20190055603, Feb 21, 2019

Filed:

Apr 28, 2016

Appl. No.:

15/570311

Inventors:

- Annapolis MD, US
Brian MESHKIN - Ladera Ranch CA, US

International Classification:

C12Q 1/6883
G16H 50/20
C12Q 1/02
G06F 19/10
G16H 10/60

Abstract:

There are systems and methods for preparing or using prognostic information about drug metabolism response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more alleles or haplotypes in the one or more genes of the subject genotype by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more alleles or haplotypes.

US Patent:

20190018923, Jan 17, 2019

Filed:

Apr 28, 2016

Appl. No.:

15/570317

Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US

International Classification:

G06F 19/18
G06F 19/22
G16H 50/30
G16H 10/60

Abstract:

There are systems and methods for preparing or using prognostic information about opioid maintenance response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining an opioid maintenance response associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

US Patent:

20180322960, Nov 8, 2018

Filed:

Apr 28, 2016

Appl. No.:

15/570315

Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US

International Classification:

G16H 70/40
G06F 19/22
G06F 19/28
G06F 19/18

Abstract:

There are systems and methods for preparing or using prognostic information about NSAID mediated side effect risks. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining a NSAID mediated side effect risk associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

US Patent:

20180247013, Aug 30, 2018

Filed:

Apr 28, 2016

Appl. No.:

15/570314

Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US

International Classification:

G06F 19/22
C12Q 1/6876
G06F 19/18

Abstract:

There are systems and methods for preparing or using prognostic information about non-opioid response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining a non-opioid response associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

US Patent:

20180137235, May 17, 2018

Filed:

Apr 28, 2016

Appl. No.:

15/570306

Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US

International Classification:

G06F 19/18
G06F 19/22
G16H 50/30
G16H 10/60

Abstract:

There are methods, apparati and computer readable mediums associated with determining patient information, including DNA information, and determining from the DNA information whether a subject genotype of a human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype. The SNP diploid polymorphisms are selected from a SNP diploid group and utilized in determining an opioid dependency risk associated with the human subject.

US Patent:

20150310164, Oct 29, 2015

Filed:

Apr 24, 2015

Appl. No.:

14/695695

Inventors:

- Annapolis Junction MD, US
Brian MESHKIN - Fulton MD, US

International Classification:

G06F 19/18
C12Q 1/68

Abstract:

There are systems and methods for preparing or using prognostic information about pain perception or performing an assay based on such information. The information may include whether subject has a subject genotype that includes a COMT haplotype diploid, at least two SNP diploids, one or more demographic phenotypes or a combination thereof. The COMT haplotype diploid is a combination of two COMT haplotypes selected from an LPS haplotype, an APS haplotype, a HPS haplotype or a combination thereof in the COMT gene. The at least two SNP diploids are each a combination of two SNP alleles associated with one SNP location in the DRD1 gene, the COMT gene, the OPRK1 gene, the DRD2 gene, the MTHFR gene, the SLC6A4 gene, the HTR2A gene, the DBH gene, the GABRG2 gene, the OPRM1 gene or the SLC6A3 gene.

US Patent:

20150161358, Jun 11, 2015

Filed:

Dec 6, 2013

Appl. No.:

14/099368

Inventors:

Brian Meshkin - Irvine CA, US
Brian Meshkin - Fulton MD, US

International Classification:

G06F 19/00

Abstract:

There is a system and a method for performing medical research. The method includes receiving a registration record. The registration record is for documenting a participant's involvement in a clinical trial. The method may also include receiving an evaluation record for documenting biological information associated with the participant in the clinical trial. The method may also include generating a payment record. The payment record may include a payment value associated with the evaluation record. The registration record may include a service authorization. The service authorization may be for a service the participant receives for collecting the biological information.